Stockreport

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024 [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF molecule therapies for chronic inflammatory and autoimmune diseases, today announced the presentation of data from the company's phase 2 CALLIPER and CALVID-1 clinical t [Read more]